Business Context and Reporting Period
This Form 8-K filing by Pacific Biosciences of California, Inc. (PACB) reports a material change in corporate leadership. The report date is December 5, 2024, covering events effective December 5 and December 6, 2024.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Resignation: Susan G. Kim resigned as Chief Financial Officer and principal financial officer, effective December 6, 2024.
- Appointment: Christian Henry, the Company's President and Chief Executive Officer, was appointed as interim Chief Financial Officer and designated as the principal financial officer, effective December 5, 2024.
- Compensation: No change to Mr. Henry's compensation was made in connection with this appointment.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on future performance, risks, contingencies, or unusual items. The document is limited to the disclosure of the officer departure and appointment.
Investor Verification Checklist
- Verify the effective date of Susan G. Kim's resignation (December 6, 2024).
- Confirm Christian Henry's dual role as CEO and interim CFO.
- Review the definitive proxy statement filed on April 29, 2024, for background information on Christian Henry as referenced in the filing.
- Monitor future filings for the appointment of a permanent Chief Financial Officer.